California Public Employees Retirement System
KROS icon

California Public Employees Retirement System’s Keros Therapeutics KROS Stock Holding History

California Public Employees Retirement System’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,373
Closed -$1.62M – 2264
2021
Q1 		$1.62M Sell
26,373
-2,452
-9% -$155K ﹤0.01% 2161
2020
Q4 		$2.03M Buy
28,825
+12,806
+80% +$807K ﹤0.01% 1977
2020
Q3 		$618K Buy
16,019
+600
+4% +$23.8K ﹤0.01% 2626
2020
Q2 		$578K Buy
+15,419
New +$475K ﹤0.01% 2601

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

California Public Employees Retirement System's KROS Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Keros Therapeutics (KROS) in Q2 2021, closing a stake of 26,373 shares — an estimated $1.62M sold.

California Public Employees Retirement System first reported a position in KROS in Q2 2020 and held it in 4 quarters. The position peaked at $2.03M in Q4 2020. 80 funds tracked by Wall St. Rank hold KROS as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Keros Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 26,373 Keros Therapeutics shares in Q2 2021, an estimated $1.62M.
  • California Public Employees Retirement System first reported a position in Keros Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Keros Therapeutics position peaked at $2.03M in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.